OBJECTIVES: The goal of this study was to characterize left ventricular diastolic function in the sickle cell disease (SCD) population and to relate echocardiographic measures of dysfunction with pulmonary hypertension and mortality. BACKGROUND: Pulmonary hypertension has been identified as a predictor of death in the adult SCD population. Although diastolic dysfunction is also observed in this population, its prevalence, association with high pulmonary artery systolic pressure, and attributable mortality remain unknown. METHODS: Diastolic function assessment using tissue Doppler imaging was performed in a group of 141 SCD patients. Conventional echocardiographic parameters of diastolic function were performed in a total of 235 SCD patients. RESULTS: Diastolic dysfunction was present in 18% of patients. A combination of diastolic dysfunction and pulmonary hypertension was present in 11% of patients, and diastolic dysfunction accounted for only 10% to 20% of the variability in tricuspid regurgitation (TR) jet velocity. Diastolic dysfunction, as reflected by a low E/A ratio, was associated with mortality with a risk ratio of 3.5 (95% confidence interval 1.5 to 8.4, p < 0.001), even after adjustment for tricuspid regurgitation (TR) jet velocity. The presence of both diastolic dysfunction and pulmonary hypertension conferred a risk ratio for death of 12.0 (95% confidence interval 3.8 to 38.1, p < 0.001). CONCLUSIONS: Diastolic dysfunction and pulmonary hypertension each contribute independently to prospective mortality in patients with SCD. Patients with both risk factors have an extremely poor prognosis. These data support the implementation of echocardiographic screening of adult patients with SCD to identify high-risk individuals for further evaluation.
OBJECTIVES: The goal of this study was to characterize left ventricular diastolic function in the sickle cell disease (SCD) population and to relate echocardiographic measures of dysfunction with pulmonary hypertension and mortality. BACKGROUND:Pulmonary hypertension has been identified as a predictor of death in the adult SCD population. Although diastolic dysfunction is also observed in this population, its prevalence, association with high pulmonary artery systolic pressure, and attributable mortality remain unknown. METHODS: Diastolic function assessment using tissue Doppler imaging was performed in a group of 141 SCDpatients. Conventional echocardiographic parameters of diastolic function were performed in a total of 235 SCDpatients. RESULTS:Diastolic dysfunction was present in 18% of patients. A combination of diastolic dysfunction and pulmonary hypertension was present in 11% of patients, and diastolic dysfunction accounted for only 10% to 20% of the variability in tricuspid regurgitation (TR) jet velocity. Diastolic dysfunction, as reflected by a low E/A ratio, was associated with mortality with a risk ratio of 3.5 (95% confidence interval 1.5 to 8.4, p < 0.001), even after adjustment for tricuspid regurgitation (TR) jet velocity. The presence of both diastolic dysfunction and pulmonary hypertension conferred a risk ratio for death of 12.0 (95% confidence interval 3.8 to 38.1, p < 0.001). CONCLUSIONS:Diastolic dysfunction and pulmonary hypertension each contribute independently to prospective mortality in patients with SCD. Patients with both risk factors have an extremely poor prognosis. These data support the implementation of echocardiographic screening of adult patients with SCD to identify high-risk individuals for further evaluation.
Authors: Kenneth I Ataga; Namita Sood; Guy De Gent; Eileen Kelly; Ashley G Henderson; Susan Jones; Dell Strayhorn; Alice Lail; Susan Lieff; Eugene P Orringer Journal: Am J Med Date: 2004-11-01 Impact factor: 4.965
Authors: Shahid Ahmed; Anita K Siddiqui; Adnan Sadiq; Rabia K Shahid; Dilip V Patel; Linda A Russo Journal: Am J Hematol Date: 2004-07 Impact factor: 10.047
Authors: Elizabeth A Manci; Donald E Culberson; Yih-Ming Yang; Todd M Gardner; Randall Powell; Johnson Haynes; Arvind K Shah; Vipul N Mankad Journal: Br J Haematol Date: 2003-10 Impact factor: 6.998
Authors: Mark T Gladwin; Vandana Sachdev; Maria L Jison; Yukitaka Shizukuda; Jonathan F Plehn; Karin Minter; Bernice Brown; Wynona A Coles; James S Nichols; Inez Ernst; Lori A Hunter; William C Blackwelder; Alan N Schechter; Griffin P Rodgers; Oswaldo Castro; Frederick P Ognibene Journal: N Engl J Med Date: 2004-02-26 Impact factor: 91.245
Authors: Marius George Linguraru; John A Pura; Robert L Van Uitert; Nisha Mukherjee; Ronald M Summers; Caterina Minniti; Mark T Gladwin; Gregory Kato; Roberto F Machado; Bradford J Wood Journal: Med Phys Date: 2010-04 Impact factor: 4.071
Authors: Robyn J Barst; Kamal K Mubarak; Roberto F Machado; Kenneth I Ataga; Raymond L Benza; Oswaldo Castro; Robert Naeije; Namita Sood; Paul S Swerdlow; Mariana Hildesheim; Mark T Gladwin Journal: Br J Haematol Date: 2010-02-17 Impact factor: 6.998
Authors: Marius George Linguraru; Babak J Orandi; Robert L Van Uitert; Nisha Mukherjee; Ronald M Summers; Mark T Gladwin; Roberto F Machado; Bradford J Wood Journal: Conf Proc IEEE Eng Med Biol Soc Date: 2008
Authors: Claudia R Morris; Hae-Young Kim; Elizabeth S Klings; John Wood; John B Porter; Felicia Trachtenberg; Nancy Sweeters; Nancy F Olivieri; Janet L Kwiatkowski; Lisa Virzi; Kathryn Hassell; Ali Taher; Ellis J Neufeld; Alexis A Thompson; Sandra Larkin; Jung H Suh; Elliott P Vichinsky; Frans A Kuypers Journal: Br J Haematol Date: 2015-04-24 Impact factor: 6.998
Authors: Kiona Y Allen; Shannon Jones; Tannoa Jackson; Grace DeCost; Paul Stephens; Brian D Hanna; Meryl S Cohen; Kim Smith-Whitley; Laura Mercer-Rosa; Shobha S Natarajan Journal: Pediatr Cardiol Date: 2019-09-21 Impact factor: 1.655
Authors: Sergei Nekhai; Min Xu; Altreisha Foster; Ishmael Kasvosve; Sharmin Diaz; Roberto F Machado; Oswaldo L Castro; Gregory J Kato; James G Taylor; Victor R Gordeuk Journal: Haematologica Date: 2012-10-12 Impact factor: 9.941